A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

But patients would rather treat their sleep apnea with tirzepatide (Zepbound), a GLP-1 weight-loss drug, researchers found. "The results highlight a need for real-world comparative effectiveness ...

Sleep Apnea Treatment Clash: Doctors prefer CPAP, but obese patients lean towards Zepbound. Explore this growing healthcare debate. MONDAY, June 9, 2025 ... Patients, Doctors Debate Sleep Apnea ...

But patients with obesity would rather use Zepbound to ease their apnea ...